![](/img/cover-not-exists.png)
338 BM-1252 (APG-1252): a potent dual specific Bcl-2/Bcl-xL inhibitor that achieves complete tumor regression with minimal platelet toxicity
Bai, L., Chen, J., Liu, L., McEachern, D., Aguilar, A., Zhou, H., Yang, C.Y., Wang, H., Wen, J., Wang, G., Zhai, Y., Guo, M., Yang, D., Wang, S.Volume:
50
Language:
english
Journal:
European Journal of Cancer
DOI:
10.1016/S0959-8049(14)70464-2
Date:
November, 2014
File:
PDF, 78 KB
english, 2014